{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T04:09:45Z","timestamp":1767499785258,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"TUBITAK","award":["215S197"],"award-info":[{"award-number":["215S197"]}]},{"name":"SAS-TUBITAK","award":["JRP 2015\/7"],"award-info":[{"award-number":["JRP 2015\/7"]}]},{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"crossref","award":["APVV-15-0455"],"award-info":[{"award-number":["APVV-15-0455"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Slovak Grant Agency of the Ministry of Education","award":["VEGA 2\/0005\/2018"],"award-info":[{"award-number":["VEGA 2\/0005\/2018"]}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"crossref","award":["R01ES03771"],"award-info":[{"award-number":["R01ES03771"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"crossref","award":["R01ES10563"],"award-info":[{"award-number":["R01ES10563"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12640-021-00349-7","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T06:02:32Z","timestamp":1615615352000},"page":"588-597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Protective Effects of Novel Substituted Triazinoindole Inhibitors of Aldose Reductase and Epalrestat in Neuron-like PC12 Cells and BV2 Rodent Microglial Cells Exposed to Toxic Models of Oxidative Stress: Comparison with the Pyridoindole Antioxidant Stobadine"],"prefix":"10.1007","volume":"39","author":[{"given":"Zubeyir","family":"Elmazoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta Soltesova","family":"Prnova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Stefek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asli F.","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Rangel-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abel","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cimen","family":"Karasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,13]]},"reference":[{"key":"349_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1085-9489.2006.00085.x","volume":"11","author":"M Baba","year":"2006","unstructured":"Baba M, Kimura K, Suda T, Yagihashi S (2006) Aomori Diabetic Study (ADNS) Group. Three-year inhibition of aldose reductase on development of symptomatic neuropathy in diabetic patients. J Peripher Nerv Syst 11:176\u2013178","journal-title":"J Peripher Nerv Syst"},{"key":"349_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2478\/intox-2014-0005","volume":"7","author":"A Balcerczyk","year":"2014","unstructured":"Balcerczyk A, Bartosz G, Drzewinska J, Piotrowski \u0141, Pulaski \u0141, Stefek M (2014) Antioxidant action of SMe1EC2, the low-basicity derivative of the pyridoindole stobadine, in cell free chemical models and at cellular level. Interdiscip Toxicol 7:27\u201332","journal-title":"Interdiscip Toxicol"},{"key":"349_CR3","doi-asserted-by":"publisher","first-page":"S233","DOI":"10.1097\/01.ASN.0000077408.15865.06","volume":"14","author":"SS Chung","year":"2003","unstructured":"Chung SS, Ho EC, Lam KS, Chung SK (2003) Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 14:S233\u2013S236","journal-title":"J Am Soc Nephrol"},{"key":"349_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/biof.5520300304","volume":"30","author":"A Cumaoglu","year":"2007","unstructured":"Cumaoglu A, Cevik C, Rackova L, Ari N, Karasu C (2007) Effects of antioxidant stobadine on protein carbonylation, advanced oxidation protein products and reductive capacity of liver in streptozotocin-diabetic rats: role of oxidative\/nitrosative stress. BioFactors 30:171\u2013178","journal-title":"BioFactors"},{"key":"349_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-020-00305-x","author":"Z Elmazoglu","year":"2020","unstructured":"Elmazoglu Z, Prnova MS, Santamaria A, Stefek M, Karasu C (2020) Combatting nitrosative stress and inflammation with novel substituted triazinoindole inhibitors of aldose reductase in PC12 cells exposed to 6-hydroxydopamine plus high glucose. Neurotox Res. 39:210-226.\u00a0https:\/\/doi.org\/10.1007\/s12640-020-00305-x","journal-title":"Neurotox Res"},{"key":"349_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1440-1681.2007.04574.x","volume":"34","author":"G Guz","year":"2007","unstructured":"Guz G, Demirogullari B, Ulusu NN, Dogu C, Demirtola A, Kavutcu M, Omeroglu S, Stefek M, Karasu C (2007) Stobadine protects rat kidney against ischaemia\/reperfusion injury. Clin Exp Pharmacol Physiol 34:210\u2013216","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"349_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1021\/acs.jmedchem.9b01747","volume":"63","author":"M Hlavac","year":"2020","unstructured":"Hlavac M, Kovacikova L, Soltesova Prnova M, \u0160ramel P, Addova G, Majekova M, Hanquet G, Bohac A, Stefek M (2020) Development of novel oxotriazinoindole inhibitors of aldose reductase: isosteric sulfur\/oxygen replacement in the thioxotriazinoindole cemtirestat markedly improved inhibition selectivity. J Med Chem 63:369\u2013381","journal-title":"J Med Chem"},{"key":"349_CR8","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.040584","author":"S Iyer","year":"2019","unstructured":"Iyer S, Sam FS, DiPrimio N, Preston G, Verheijen J, Murthy K, Parton Z, Tsang H, Lao J, Morava E, Perlstein EO (2019) Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG. Dis Model Mech. https:\/\/doi.org\/10.1242\/dmm.040584","journal-title":"Dis Model Mech"},{"key":"349_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.2174\/092986710790416317","volume":"17","author":"I Juranek","year":"2010","unstructured":"Juranek I, Horakova L, Rackova L, Stefek M (2010) Antioxidants in treating pathologies involving oxidative damage: an update on medicinal chemistry and biological activity of stobadine and related pyridoindoles. Curr Med Chem 17:552\u2013570","journal-title":"Curr Med Chem"},{"key":"349_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2478\/v10102-012-0003-8","volume":"5","author":"C Karasu","year":"2012","unstructured":"Karasu C, Cumao\u011flu A, G\u00fcrpinar AR, Kartal M, Kovacikova L, Milackova I, Stefek M (2012) Aldose reductase inhibitory activity and antioxidant capacity of pomegranate extracts. Interdiscip Toxicol 5:15\u201320","journal-title":"Interdiscip Toxicol"},{"key":"349_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/cells10020233","volume":"10","author":"T Konno","year":"2021","unstructured":"Konno T, Melo EP, Chambers JE, Avezov E (2021) Intracellular sources of ROS\/H(2)O(2) in health and neurodegeneration: spotlight on endoplasmic reticulum. Cells 10:233","journal-title":"Cells"},{"key":"349_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4103\/1673-5374.177745","volume":"11","author":"QR Li","year":"2016","unstructured":"Li QR, Wang Z, Zhou W, Fan SR, Ma R, Xue L, Yang L, Li YS, Tan HL, Shao QH, Yang HY (2016) Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway. Neural Regen Res 11:345\u2013351","journal-title":"Neural Regen Res"},{"key":"349_CR13","doi-asserted-by":"publisher","first-page":"644","DOI":"10.2174\/1871527317666180809092359","volume":"17","author":"NK Mule","year":"2018","unstructured":"Mule NK, Singh JN (2018) Diabetes mellitus to neurodegenerative disorders: is oxidative stress fueling the flame? CNS Neurol Disord Drug Targets 17:644\u2013653","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"349_CR14","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.2337\/diacare.24.6.1093","volume":"24","author":"M Nakayama","year":"2001","unstructured":"Nakayama M, Nakamura J, Hamada Y, Chaya S, Mizubayashi R, Yasuda Y, Kamiya H, Koh N, Hotta N (2001) Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy. Diabetes Care 24:1093\u20131098","journal-title":"Diabetes Care"},{"key":"349_CR15","doi-asserted-by":"publisher","first-page":"e1654","DOI":"10.1212\/WNL.0000000000005475","volume":"90","author":"G Pagano","year":"2018","unstructured":"Pagano G, Polychronis S, Wilson H, Giordano B, Ferrara N, Niccolini F, Politis M (2018) Diabetes mellitus and Parkinson disease. Neurology 90:e1654\u2013e1662","journal-title":"Neurology"},{"key":"349_CR16","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00018-003-3402-3","volume":"61","author":"JM Petrash","year":"2004","unstructured":"Petrash JM (2004) All in the family: aldose reductase and closely related aldo-keto reductases. Cell Mol Life Sci 61:737\u2013749","journal-title":"Cell Mol Life Sci"},{"key":"349_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1179\/1351000215Y.0000000019","volume":"20","author":"MS Prnova","year":"2015","unstructured":"Prnova MS, Ballekova J, Majekova M, Stefek M (2015) Antioxidant action of 3-mercapto-5H-1,2,4-triazino[5,6-b]indole-5-acetic acid, an efficient aldose reductase inhibitor, in a 1,1\u2019-diphenyl-2-picrylhydrazyl assay and in the cellular system of isolated erythrocytes exposed to tert-butyl hydroperoxide. Redox Rep 20:282\u2013288","journal-title":"Redox Rep"},{"key":"349_CR18","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00210-019-01769-1","volume":"393","author":"MS Prnova","year":"2020","unstructured":"Prnova MS, Kovacikova L, Svik K, Bezek S, Elmazo\u011flu Z, Karasu C, Stefek M (2020) Triglyceride-lowering effect of the aldose reductase inhibitor cemtirestat-another factor that may contribute to attenuation of symptoms of peripheral neuropathy in STZ-diabetic rats. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 393:651\u2013661","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"349_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1179\/135100002125000578","volume":"7","author":"L Rackova","year":"2002","unstructured":"Rackova L, Stefek M, Majekova M (2002) Structural aspects of antioxidant activity of substituted pyridoindoles. Redox Rep 7:207\u2013214","journal-title":"Redox Rep"},{"key":"349_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2174\/157340611797928370","volume":"7","author":"L Rackova","year":"2011","unstructured":"Rackova L, Cumaoglu A, Bagr\u0131ac\u0131k EU, Stefek M, Maechler P, Karasu C (2011) Novel hexahydropyridoindole derivative as prospective agent against oxidative damage in pancreatic \u03b2 cells. Med Chem 7:711\u2013717","journal-title":"Med Chem"},{"key":"349_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.14336\/AD.2015.0823","volume":"7","author":"P Sch\u00f6nfeld","year":"2016","unstructured":"Sch\u00f6nfeld P, Reiser G (2016) Brain lipotoxicity of phytanic acid and very long-chain fatty acids. Harmful cellular\/mitochondrial activities in Refsum disease and X-linked adrenoleukodystrophy. Aging Dis 7:136\u2013149","journal-title":"Aging Dis"},{"key":"349_CR22","doi-asserted-by":"publisher","first-page":"6785852","DOI":"10.1155\/2017\/6785852","volume":"2017","author":"K Shukla","year":"2017","unstructured":"Shukla K, Pal PB, Sonowal H, Srivastava SK, Ramana KV (2017) Aldose reductase inhibitor protects against hyperglycemic stress by activating Nrf2-dependent antioxidant proteins. J Diabetes Res 2017:6785852","journal-title":"J Diabetes Res"},{"key":"349_CR23","first-page":"106","volume":"27","author":"S Skalska","year":"2008","unstructured":"Skalska S, Kyselova Z, Gajdosikova A, Karasu C, Stefek M, Stolc S (2008) Protective effect of stobadine on NCV in streptozotocin-diabetic rats: augmentation by vitamin E. Gen Physiol Biophys 27:106\u2013114","journal-title":"Gen Physiol Biophys"},{"key":"349_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neuroscience.2020.07.014","volume":"443","author":"M Soltesova Prnova","year":"2020","unstructured":"Soltesova Prnova M, Medina-Campos ON, Pedraza-Chaverri J, Col\u00edn-Gonz\u00e1lez AL, Piedra-Garc\u00eda F, Rangel-L\u00f3pez E, Kovacikova L, Ceylan A, Karasu C, Santamaria A, Stefek M (2020) Antioxidant mechanisms in the neuroprotective action of cemtirestat: studies in chemical models, liposomes and rat brain cortical slices. Neuroscience 443:206\u2013217","journal-title":"Neuroscience"},{"key":"349_CR25","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s11064-019-02736-1","volume":"44","author":"M Soltesova Prnova","year":"2019","unstructured":"Soltesova Prnova M, Svik K, Bezek S, Kovacikova L, Karasu C, Stefek M (2019) 3-Mercapto-5H-1,2,4-triazino[5,6-b]indole-5-acetic acid (cemtirestat) alleviates symptoms of peripheral diabetic neuropathy in Zucker diabetic fatty (ZDF) rats: a role of aldose reductase. Neurochem Res 44:1056\u20131064","journal-title":"Neurochem Res"},{"key":"349_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1179\/1351000213Y.0000000043","volume":"18","author":"M Stefek","year":"2013","unstructured":"Stefek M, Milackova I, Juskova-Karasova M, Snirc V (2013) Antioxidant action of the hexahydropyridoindole SMe1EC2 in the cellular system of isolated red blood cells in vitro. Redox Rep 18:71\u201375","journal-title":"Redox Rep"},{"key":"349_CR27","first-page":"41","volume":"4","author":"M Stefek","year":"2016","unstructured":"Stefek M, Soltesova Prnova M, Ballekova J, Majekova M (2016) Cemtirestat, a novel aldose reductase inhibitor and antioxidant, in multitarget pharmacology of diabetic complications. International Journal of Advances in Science Engineering and Technology IRAJ 4:41\u201344","journal-title":"International Journal of Advances in Science Engineering and Technology IRAJ"},{"key":"349_CR28","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1021\/jm5015814","volume":"58","author":"M Stefek","year":"2015","unstructured":"Stefek M, Soltesova Prnova M, Majekova M, Rechlin C, Heine A, Klebe G (2015) Identification of novel aldose reductase inhibitors based on carboxymethylated mercaptotriazinoindole scaffold. J Med Chem 58:2649\u20132657","journal-title":"J Med Chem"},{"key":"349_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1515\/intox-2017-0021","volume":"10","author":"NN Ulusu","year":"2017","unstructured":"Ulusu NN, G\u00f6k M, Sayin \u015eakul AA, Ari N, Stefek M, Karasu C (2017) \u201cThe ADIC (Antioxidants in Diabetes-Induced Complications) Study Group\u201d. Antioxidant SMe1EC2 modulates pentose phosphate pathway and glutathione-dependent enzyme activities in tissues of aged diabetic rats. Interdiscip Toxicol 10:148\u2013154","journal-title":"Interdiscip Toxicol"},{"key":"349_CR30","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/mds.26566","volume":"31","author":"H Vicente Miranda","year":"2016","unstructured":"Vicente Miranda H, El-Agnaf OM, Outeiro TF (2016) Glycation in Parkinson\u2019s disease and Alzheimer\u2019s disease. Mov Disord 31:782\u2013790","journal-title":"Mov Disord"},{"key":"349_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neurobiolaging.2016.11.008","volume":"50","author":"PKK Yeung","year":"2017","unstructured":"Yeung PKK, Lai AKW, Son HJ, Zhang X, Hwang O, Chung SSM, Chung SK (2017) Aldose reductase deficiency leads to oxidative stress-induced dopaminergic neuronal loss and autophagic abnormality in an animal model of Parkinson\u2019s disease. Neurobiol Aging 50:119\u2013133","journal-title":"Neurobiol Aging"},{"key":"349_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-020-03198-6","author":"J Zhang","year":"2021","unstructured":"Zhang J, Song N, Liu Y, Guo J (2021) Platycodin D inhibits beta-amyloid-induced inflammation and oxidative stress in BV-2 cells via suppressing TLR4\/NF-kappaB signaling pathway and activating Nrf2\/HO-1 signaling pathway. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-020-03198-6","journal-title":"Neurochem Res"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-021-00349-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-021-00349-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-021-00349-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T04:53:05Z","timestamp":1620103985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-021-00349-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,13]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["349"],"URL":"https:\/\/doi.org\/10.1007\/s12640-021-00349-7","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"type":"print","value":"1029-8428"},{"type":"electronic","value":"1476-3524"}],"subject":[],"published":{"date-parts":[[2021,3,13]]},"assertion":[{"value":"20 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human and Animal Participants"}}]}}